home / stock / lxxgf / lxxgf news

LXXGF News and Press, Lexagene Holdings From 04/25/22

Stock Information
Company Name: Lexagene Holdings
Stock Symbol: LXXGF
Market: OTC
Website: lexagene.com
Menu
LXXGF LXXGF Quote LXXGF Short LXXGF News LXXGF Articles LXXGF Message Board
Get LXXGF Alerts

News, Short Squeeze, Breakout and More Instantly...
LXXGF - LexaGene announces multi-system purchase from a veterinary lab

Molecular diagnostics company, LexaGene (OTCQB:LXXGF) announces a corporate veterinary reference laboratory has purchased 3 MiQLab® Systems for one of their many locations. Dr. Jack Regan, CEO and Founder stated, “Testing in the veterinary industry is domi...
LXXGF - LexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference Laboratory

BEVERLY, Mass., April 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, i...

LXXGF - LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market

BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System , a fully automated rapid pathogen testing devi...

LXXGF - LexaGene Announces Closing of Second Tranche of Investment by Strategic Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a ...
LXXGF - LexaGene Announces $6.4 Million Investment by Strategic Institutional Investor

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a ...

LXXGF - LexaGene Starts the Year with Additional MiQLab Sales

BEVERLY, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce t...

LXXGF - LexaGene Announces Results of Annual General and Special Meeting

BEVERLY, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to annou...
LXXGF - LexaGene Closes Multiple MiQLab Sales

BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce two purchase...

LXXGF - LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA

BEVERLY, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testin...

LXXGF - Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors

BEVERLY, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testin...
Previous 10 Next 10